Bulletin
Investor Alert

New York Markets Close in:

Edesa Biotech Inc.

NAS: EDSA

GO
/marketstate/country/us

Market open

 --Quotes are delayed by 20 min

Nov 28, 2022, 1:40 p.m.

/zigman2/quotes/200172674/composite

$

0.93

Change

+0.03 +3.48%

Volume

Volume 43,957

Quotes are delayed by 20 min

/zigman2/quotes/200172674/composite

Previous close

$ 0.90

$ 0.93

Change

+0.03 +3.48%

Day low

Day high

$0.88

$0.93

Open

52 week low

52 week high

$0.76

$6.72

Open

Annual Financials for Edesa Biotech Inc.

Fiscal year is October-September. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 228,287211,849547,825328,801-
Cost of Goods Sold (COGS) incl. D&A 534,453445,320135,04875,164118,788
COGS excluding D&A 355,131256,948128,67617,601-
Depreciation & Amortization Expense 179,322188,3726,37257,563118,788
Depreciation 179,322188,3726,372-17,616
Amortization of Intangibles ----101,172
Gross Income (306,166)(233,471)412,778253,637(118,788)
20172018201920202021 5-year trend
SG&A Expense 4.92M4.84M4.19M6.65M23.56M
Research & Development 1.97M2.09M1.46M3.33M17.95M
Other SG&A 2.94M2.76M2.73M3.33M-
Other Operating Expense -----
Unusual Expense ----(10.34M)
EBIT after Unusual Expense ----(13.34M)
Non Operating Income/Expense 162,030(35,060)(1,910)(370)(13,020)
Non-Operating Interest Income 32,67075,16075,78637,77811,165
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (5.03M)(5.04M)(3.7M)(6.36M)(13.34M)
Income Tax 800800-800800
Income Tax - Current Domestic 2.12M(1.13M)-800800
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic (667,400)(904,400)---
Income Tax - Deferred Foreign (1.45M)2.04M---
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (5.03M)(5.04M)(3.7M)(6.36M)(13.34M)
Minority Interest Expense -----
Net Income (5.03M)(5.04M)(3.7M)(6.36M)(13.34M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (5.03M)(5.04M)(3.7M)(6.36M)(13.34M)
Preferred Dividends -----
Net Income Available to Common (5.03M)(5.04M)(3.7M)(6.36M)(13.34M)
EPS (Basic) (20.58)(10.54)(0.74)(0.74)(1.10)
Basic Shares Outstanding 243,743478,2295.04M8.61M12.08M
EPS (Diluted) (20.58)(10.54)(0.74)(0.74)(1.10)
Diluted Shares Outstanding 243,743478,2295.04M8.61M12.08M
EBITDA (5.05M)(4.89M)(3.77M)(6.34M)(23.56M)
Link to MarketWatch's Slice.